AXSAIN

This brand name is authorized in Ireland, UK.

Active ingredients

The drug AXSAIN contains one active pharmaceutical ingredient (API):

1	Capsaicin UNII S07O44R1ZM - CAPSAICIN
	Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides.
	Read more about Capsaicin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AXSAIN Cream	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AB01	Capsaicin	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AB Capsaicin and similar agents
Discover more medicines within M02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	22469
IE	Health Products Regulatory Authority	50905